AUG 8·SEC EDGARLow
Blunt Roy sold $158K of THC
Blunt Roy sold 600 shares of TENET HEALTHCARE CORP (THC) at $262.68 ($0.16M total) on 2026-08-05.
StockNYSE · US · USDHealthcare · Medical Care Facilities
$THC
TENET HEALTHCARE CORP
Price · $THCvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $THC in the last 7 days.
Top stories · $THCMore →
AUG 1·beckersasc.com
Could the 340B/HOPD rule ripple into ASC reimbursement?
Tenet Healthcare said on its July 24 Q2 earnings call it is still modeling how CMS’s July 2 proposed 2027 OPPS/ASC rule could affect its ASCs. CMS would cut 340B drug payments to hospitals, expand site-neutral outpatient categories, and raise a 340B offset conversion factor to 3% to recover $7.8B by 2029. Tenet projects USPI adjusted EBITDA of $2.16B to $2.22B in 2026.
AUG 1·SEC EDGAR
Foo Lisa Y sold $2.6M of THC
Foo Lisa Y (EVP, Chief Operating Officer) sold 10,000 shares of TENET HEALTHCARE CORP (THC) at $258.03 ($2.58M total) on 2026-07-29.
THC sentiment & insider activity
Recent THC coverage spans insider activity, earnings and regulation.
In the last 30 days, THC insiders filed 5 SEC Form 4 transactions — no purchases and 5 sales ($7.5M). The most active reporter was Blunt Roy with 1 filing.
What's driving THC
This is a routine insider sale disclosure with no 10b5-1 plan stated, but it does not by itself signal a fundamental change.
Regulatory reimbursement changes could shift marginal hospital outpatient procedures to ASCs, but Tenet is still quantifying legal and financial impacts.
This is a routine insider sale with no stated 10b5-1 plan, but it does not by itself signal a new fundamental change.
Direct management read-through that ACA-exchange volume is converting into uninsured, increasing uncompensated care exposure.
This is a routine insider open-market sale with no stated 10b5-1 plan, but it does not disclose new company fundamentals.
alphai scores every news story that mentions THC with an AI model for sentiment and relevance, and aggregates insider trades from TENET HEALTHCARE CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $THC
Score
Blunt Roy sold $158K of THC
Blunt Roy sold 600 shares of TENET HEALTHCARE CORP (THC) at $262.68 ($0.16M total) on 2026-08-05.
2 min read
Could the 340B/HOPD rule ripple into ASC reimbursement?
Tenet Healthcare said on its July 24 Q2 earnings call it is still modeling how CMS’s July 2 proposed 2027 OPPS/ASC rule could affect its ASCs. CMS would cut 340B drug payments to hospitals, expand site-neutral outpatient categories, and raise a 340B offset conversion factor to 3% to recover $7.8B by 2029. Tenet projects USPI adjusted EBITDA of $2.16B to $2.22B in 2026.
6 min readFoo Lisa Y sold $2.6M of THC
Foo Lisa Y (EVP, Chief Operating Officer) sold 10,000 shares of TENET HEALTHCARE CORP (THC) at $258.03 ($2.58M total) on 2026-07-29.
2 min readUninsured patients rise sharply, hospitals report, citing Obamacare cuts | Chattanooga Times Free Press
More and more uninsured patients are showing up in hospital emergency rooms and clinics, having lost their coverage under the Affordable Care Act. Executives running some of the biggest hospital systems, including large for-profit chains spanning many states, expressed concern over the unexpectedly sharp rise in uninsured patients and the costs associated with treating them.
7 min readLynch Christopher S. sold $934K of THC
Lynch Christopher S. sold 3,837 shares of TENET HEALTHCARE CORP (THC) at $243.44 ($0.93M total) on 2026-07-27.
1 min readArbour Paola M sold $2.7M of THC
Arbour Paola M (EVP, Chief Information Officer) sold 10,878 shares of TENET HEALTHCARE CORP (THC) at $243.90 ($2.65M total) on 2026-07-27.
1 min readBIERMAN JAMES L sold $1.2M of THC
BIERMAN JAMES L sold 5,000 shares of TENET HEALTHCARE CORP (THC) at $244.96 ($1.22M total) on 2026-07-27.
2 min readTenet raises 2026 outlook after weathering ACA headwinds
Tenet Healthcare raised 2026 guidance after Q2 headwinds on Affordable Care Act exchanges. The company now expects adjusted EBITDA of $4.8B to $5.0B, up from $4.5B to $4.8B. Q2 net income rose to $826M on $5.6B revenue, though ACA revenue fell $65M as ACA admissions declined.
4 min read
Tenet Healthcare Corporation Stock 12‑Month Price Target Raised to $267.15, Implies 15% Upside
FactSet-reported analyst estimates show Tenet Healthcare (THC) raised its 12-month average price target to $267.15 from $262.65. The range is $218 to $308, implying about 15% upside versus the Jul. 24 close. Consensus remains “Buy” with 21 Buys, 4 Holds, and 0 Sells from 25 analysts.
1 min readTenet Healthcare Tops Q2 Earnings Estimates, Raises 2026 Outlook
Tenet Healthcare (THC) reported Q2 2026 adjusted EPS of $6.12, 50% above the Zacks Consensus, with net operating revenues up 6.8% to $5.63B. Adjusted net income rose 39.3% to $514M. The company raised 2026 guidance for revenue, adjusted EBITDA, and adjusted EPS, and authorized a $2B share repurchase increase.
6 min read